NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

流感:2030年前的流行病學預測

Influenza - Epidemiology Insight - 2030

出版商 DelveInsight Business Research LLP 商品編碼 966788
出版日期 按訂單生產 內容資訊 英文 100 Pages
商品交期: 10個工作天內
價格
流感:2030年前的流行病學預測 Influenza - Epidemiology Insight - 2030
出版日期: 按訂單生產內容資訊: 英文 100 Pages
簡介

本報告提供美國,德國,法國,義大利,西班牙,英國,日本等主要7個國家的流感的流行病學相關市場調查,提供疾病的背景和概要,流行病學與患者數,目前治療方法,主要專家的見解,未滿足需求等資訊。

目錄

第1章 主要調查結果

第2章 摘要整理

第3章 疾病的背景和概要

  • 簡介
  • 徵兆與症狀
  • 病理學
  • 危險因素
  • 診斷

第4章 患者的治療過程

第5章 流行病學和患者數

  • 主要調查結果
  • 前提和根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 主要7個國家的流行病學方案
  • 美國
  • 歐洲5個國家
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第6章 治療流程,目前治療和醫療

  • 治療和管理
  • 治療流程

第7章 主要專家的見解

第8章 未滿足需求

第9章 附錄

  • 參考文獻
  • 報告的調查手法

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI1063

DelveInsight's 'Influenza - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Influenza epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Influenza Understanding

The DelveInsight Influenza epidemiology report gives a thorough understanding of the Influenza by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Influenza in the US, Europe, and Japan. The report covers the detailed information of the Influenza epidemiology scenario in seven major countries (US, EU5, and Japan).

Influenza Epidemiology Perspective by DelveInsight

The Influenza epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Influenza epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Influenza epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Influenza Detailed Epidemiology Segmentation

The Influenza epidemiology covered in the report provides historical as well as forecasted Influenza epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Influenza report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Influenza report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Influenza Epidemiology Report and Model provide an overview of the risk factors and global trends of Influenza in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Influenza in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Influenza
  • The report provides the segmentation of the Influenza epidemiology

Report Highlights:

  • 11-Year Forecast of Influenza epidemiology
  • 7MM Coverage
  • Total Cases of Influenza
  • Total Cases of Influenza according to segmentation
  • Diagnosed cases of Influenza

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Influenza ?
  • What are the key findings pertaining to the Influenza epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Influenza across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Influenza ?
  • What are the currently available treatments of Influenza ?

Reasons to buy:

  • The Influenza Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Influenza market
  • Quantify patient populations in the global Influenza market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Influenza therapeutics in each of the markets covered
  • Understand the magnitude of Influenza population by its epidemiology
  • The Influenza Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Influenza

3. Influenza : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Influenza Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Influenza Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Influenza Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Influenza Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Influenza Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Influenza Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Influenza Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Influenza Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Influenza Treatment and Management
  • 6.2. Influenza Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1: Influenza Epidemiology in 7MM (2017-2030)
  • Table 2: Influenza Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Influenza Epidemiology in the United States (2017-2030)
  • Table 4: Influenza Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Influenza Epidemiology in Germany (2017-2030)
  • Table 6: Influenza Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Influenza Epidemiology in France (2017-2030)
  • Table 8: Influenza Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Influenza Epidemiology in Italy (2017-2030)
  • Table 10: Influenza Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Influenza Epidemiology in Spain (2017-2030)
  • Table 12: Influenza Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Influenza Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Influenza Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Influenza Epidemiology in Japan (2017-2030)
  • Table 16: Influenza Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Influenza Epidemiology in 7MM (2017-2030)
  • Figure 2: Influenza Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Influenza Epidemiology in the United States (2017-2030)
  • Figure 4: Influenza Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Influenza Epidemiology in Germany (2017-2030)
  • Figure 6: Influenza Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Influenza Epidemiology in France (2017-2030)
  • Figure 8: Influenza Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Influenza Epidemiology in Italy (2017-2030)
  • Figure 10: Influenza Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Influenza Epidemiology in Spain (2017-2030)
  • Figure 12: Influenza Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Influenza Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Influenza Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Influenza Epidemiology in Japan (2017-2030)
  • Figure 16: Influenza Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report